Chengyue Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chengyue Zhang has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
Junyang Zhao
Department of Ophthalmology, Beijing Children's Hospital affiliated with Capital Medical University, National Center for Children's Health, Beijing 100045, China
4 shared publicationsCarol P. Lam
15Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong
3 shared publications- E. S. Kotova
National Medical Research Center Academician S.N. Fyodorov Intersectoral Scientific and Technical Complex “Eye microsurgery”, Ministry of Health of Russia
3 shared publications Genoveva Correa-Llano
20Retinoblastoma Unit, Department of Ophthalmology, Hospital Sant Joan de Déu. Esplugues de Llobregat, Barcelona, Spain
3 shared publications- Guillermo Luis Chantada
Hospital Pereira Rossell Montevideo Uruguay
3 shared publications - Michala Burges
Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, College of Medicine, and Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee
3 shared publications
Latest Publications
- Open Access
- 12 January 2026
- Published by Elsevier in Pharmacological Research
- Vol. 224, 108098
Study on epigenetic regulatory mechanism of MBD4 with a germline loss-of-function mutation (rs140693) responsible for retinoblastoma chemoresistance via the cell cycle and apoptotic pathways
- 12 January 2026
- Published by Elsevier in Pharmacological Research
- Vol. 224, 108098
Open AccessStudy on epigenetic regulatory mechanism of MBD4 with a germline loss-of-function mutation (rs140693) responsible for retinoblastoma chemoresistance via the cell cycle and apoptotic pathways
- Open Access
- 25 February 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-8
Visual conservation treatment dilemmas in neuroblastoma with bilateral blindness
Objective To investigate the clinical features, treatment strategies, and prognosis of neuroblastoma with bilateral blindness. Methods The clinical data of five patients with bilateral blindness neuroblastoma admitted to Beijing Children’s Hospital from April 2018 to September 2020 were retrospectively collected to summarize their clinical characteristics. Results All patients were female and the median age at presentation was 25 (23, 41) months. The median intervention time from the onset of symptoms of bilateral blindness to the start of treatment was 10 (10, 12) days. All five cases were staged as stage M and grouped as high risk. Four cases were MYCN gene amplification and one case was MYCN acquisition. Five children were treated according to a high-risk neuroblastoma treatment protocol. Four children did not recover their vision after treatment, and one case improved to have light perception. All patients were effectively followed up for a median of 20 (12, 31) months, with three deaths, one tumor-free survival, and one recurrent tumor-bearing survival. Conclusion Neuroblastoma with bilateral blindness is rare in the clinic, mostly in children of young age, and is often associated with MYCN amplification and multiple metastases. Early hormone shock therapy and optic nerve decompression are beneficial for preserving the child’s vision. A joint multi-disciplinary treatment may help in the formulation of treatment decisions. Achieving a balance between good visual preservation and survival within the short optic nerve neurotherapeutic window is extremely challenging.
- 25 February 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-8
Open AccessVisual conservation treatment dilemmas in neuroblastoma with bilateral blindness
Objective To investigate the clinical features, treatment strategies, and prognosis of neuroblastoma with bilateral blindness. Methods The clinical data of five patients with bilateral blindness neuroblastoma admitted to Beijing Children’s Hospital from April 2018 to September 2020 were retrospectively collected to summarize their clinical characteristics. Results All patients were female and the median age at presentation was 25 (23, 41) months. The median intervention time from the onset of symptoms of bilateral blindness to the start of treatment was 10 (10, 12) days. All five cases were staged as stage M and grouped as high risk. Four cases were MYCN gene amplification and one case was MYCN acquisition. Five children were treated according to a high-risk neuroblastoma treatment protocol. Four children did not recover their vision after treatment, and one case improved to have light perception. All patients were effectively followed up for a median of 20 (12, 31) months, with three deaths, one tumor-free survival, and one recurrent tumor-bearing survival. Conclusion Neuroblastoma with bilateral blindness is rare in the clinic, mostly in children of young age, and is often associated with MYCN amplification and multiple metastases. Early hormone shock therapy and optic nerve decompression are beneficial for preserving the child’s vision. A joint multi-disciplinary treatment may help in the formulation of treatment decisions. Achieving a balance between good visual preservation and survival within the short optic nerve neurotherapeutic window is extremely challenging.
- 25 December 2023
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 31 (3) , 439-453
Comparative study on genomic and epigenomic profiles of retinoblastoma or tuberous sclerosis complex via nanopore sequencing and a joint screening framework
Recurrence and extraocular metastasis in advanced intraocular retinoblastoma (RB) are still major obstacles for successful treatment of Chinese children. Tuberous sclerosis complex (TSC) is a very rare, multisystemic genetic disorder characterized by hamartomatous growth. In this study, we aimed to compare genomic and epigenomic profiles with human RB or TSC using recently developed nanopore sequencing, and to identify disease-associated variations or genes. Peripheral blood samples were collected from either RB or RB/TSC patients plus their normal siblings, followed by nanopore sequencing and identification of disease-specific structural variations (SVs) and differentially methylated regions (DMRs) by a systematic biology strategy named as multiomics-based joint screening framework. In total, 316 RB- and 1295 TSC-unique SVs were identified, as well as 1072 RB- and 1114 TSC-associated DMRs, respectively. We eventually identified 6 key genes for RB for further functional validation. Knockdown of CDK19 with specific siRNAs significantly inhibited Y79 cellular proliferation and increased sensitivity to carboplatin, whereas downregulation of AHNAK2 promoted the cell growth as well as drug resistance. Those two genes might serve as potential diagnostic markers or therapeutic targets of RB. The systematic biology strategy combined with functional validation might be an effective approach for rare pediatric malignances with limited samples and challenging collection process.
- 25 December 2023
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 31 (3) , 439-453
Comparative study on genomic and epigenomic profiles of retinoblastoma or tuberous sclerosis complex via nanopore sequencing and a joint screening framework
Recurrence and extraocular metastasis in advanced intraocular retinoblastoma (RB) are still major obstacles for successful treatment of Chinese children. Tuberous sclerosis complex (TSC) is a very rare, multisystemic genetic disorder characterized by hamartomatous growth. In this study, we aimed to compare genomic and epigenomic profiles with human RB or TSC using recently developed nanopore sequencing, and to identify disease-associated variations or genes. Peripheral blood samples were collected from either RB or RB/TSC patients plus their normal siblings, followed by nanopore sequencing and identification of disease-specific structural variations (SVs) and differentially methylated regions (DMRs) by a systematic biology strategy named as multiomics-based joint screening framework. In total, 316 RB- and 1295 TSC-unique SVs were identified, as well as 1072 RB- and 1114 TSC-associated DMRs, respectively. We eventually identified 6 key genes for RB for further functional validation. Knockdown of CDK19 with specific siRNAs significantly inhibited Y79 cellular proliferation and increased sensitivity to carboplatin, whereas downregulation of AHNAK2 promoted the cell growth as well as drug resistance. Those two genes might serve as potential diagnostic markers or therapeutic targets of RB. The systematic biology strategy combined with functional validation might be an effective approach for rare pediatric malignances with limited samples and challenging collection process.
- 9 December 2023
- Published by Elsevier in Ophthalmology
- Vol. 131 (5) , 589-594
Bony Congenital Nasolacrimal Duct Obstruction
- 9 December 2023
- Published by Elsevier in Ophthalmology
- Vol. 131 (5) , 589-594
Bony Congenital Nasolacrimal Duct Obstruction
- Open Access
- 30 April 2022
- Published by Elsevier in Ophthalmology
- Vol. 129 (8) , 933-945
Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma
- 30 April 2022
- Published by Elsevier in Ophthalmology
- Vol. 129 (8) , 933-945
Open AccessMetastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma
- Open Access
- 15 April 2022
- Published by Elsevier in Ophthalmology
- Vol. 129 (8) , 923-932
High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma
- 15 April 2022
- Published by Elsevier in Ophthalmology
- Vol. 129 (8) , 923-932
Open AccessHigh-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma
- Open Access
- 1 December 2020
- Published by Elsevier in Ophthalmology
- Vol. 127 (12) , 1733-1746
A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma
- 1 December 2020
- Published by Elsevier in Ophthalmology
- Vol. 127 (12) , 1733-1746
Open AccessA Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma
- Open Access
- 1 June 2020
- Published by Elsevier in Ophthalmology Retina
- Vol. 4 (6) , 630-639
Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma
- 1 June 2020
- Published by Elsevier in Ophthalmology Retina
- Vol. 4 (6) , 630-639
Open AccessImpact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma
- Open Access
Real-time and Seamless Monitoring of Ground-level PM2.5 Using Satellite Remote Sensing
Satellite remote sensing has been reported to be a promising approach for the monitoring of atmospheric PM2.5. However, the satellite-based monitoring of ground-level PM2.5 is still challenging. First, the previously used polar-orbiting satellite observations, which can be usually acquired only once per day, are hard to monitor PM2.5 in real time. Second, many data gaps exist in satellite-derived PM2.5 due to the cloud contamination. In this paper, the hourly geostationary satellite (i.e., Himawari-8) observations were adopted for the real-time monitoring of PM2.5 in a deep learning architecture. On this basis, the satellite-derived PM2.5 in conjunction with ground PM2.5 measurements are incorporated into a spatio-temporal fusion model to fill the data gaps. Using Wuhan Urban Agglomeration as an example, we have successfully derived the real-time and seamless PM2.5 distributions. The results demonstrate that Himawari-8 satellite-based deep learning model achieves a satisfactory performance (out-of-sample cross-validation R2=0.80, RMSE=17.49 ug/m3) for the estimation of PM2.5. The missing data in satellite-derive PM2.5 are accurately recovered, with R2 between recoveries and ground measurements of 0.75. Overall, this study has inherently provided an effective strategy for the real-time and seamless monitoring of ground-level PM2.5.
Open AccessReal-time and Seamless Monitoring of Ground-level PM2.5 Using Satellite Remote Sensing
Satellite remote sensing has been reported to be a promising approach for the monitoring of atmospheric PM2.5. However, the satellite-based monitoring of ground-level PM2.5 is still challenging. First, the previously used polar-orbiting satellite observations, which can be usually acquired only once per day, are hard to monitor PM2.5 in real time. Second, many data gaps exist in satellite-derived PM2.5 due to the cloud contamination. In this paper, the hourly geostationary satellite (i.e., Himawari-8) observations were adopted for the real-time monitoring of PM2.5 in a deep learning architecture. On this basis, the satellite-derived PM2.5 in conjunction with ground PM2.5 measurements are incorporated into a spatio-temporal fusion model to fill the data gaps. Using Wuhan Urban Agglomeration as an example, we have successfully derived the real-time and seamless PM2.5 distributions. The results demonstrate that Himawari-8 satellite-based deep learning model achieves a satisfactory performance (out-of-sample cross-validation R2=0.80, RMSE=17.49 ug/m3) for the estimation of PM2.5. The missing data in satellite-derive PM2.5 are accurately recovered, with R2 between recoveries and ground measurements of 0.75. Overall, this study has inherently provided an effective strategy for the real-time and seamless monitoring of ground-level PM2.5.
- 10 October 2017
- Published by Springer Nature in La radiologia medica
- Vol. 123 (2) , 117-124
Application of a full model-based iterative reconstruction (MBIR) in 80 kVp ultra-low-dose paranasal sinus CT imaging of pediatric patients
To evaluate the clinical application of a full model-based iterative reconstruction (MBIR) algorithm in the ultra-low-dose paranasal sinus CT imaging of children.
- 10 October 2017
- Published by Springer Nature in La radiologia medica
- Vol. 123 (2) , 117-124
Application of a full model-based iterative reconstruction (MBIR) in 80 kVp ultra-low-dose paranasal sinus CT imaging of pediatric patients
To evaluate the clinical application of a full model-based iterative reconstruction (MBIR) algorithm in the ultra-low-dose paranasal sinus CT imaging of children.